| A Study in Adolescent and Adult Female Participants to Evaluate Clinical Symptom Improvement and the Safety of Gepotidacin During Treatment of Uncomplicated Urinary Tract Infections (Acute Cystitis) (NCT06597344) | GlaxoSmithKline | 2024-10-02 |
| A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD) (NCT06614725) | GlaxoSmithKline | 2024-10-01 |
| A Study to Evaluate the Effect of Itraconazole on the Concentration of GSK3923868 in the Blood in Healthy Participants (NCT06597500) | GlaxoSmithKline | 2024-09-30 |
| A Study on the Safety and Immune Response to an mRNA-based RSV Investigational Vaccine in Healthy Adults Aged 18-45 Years (NCT06573281) | GlaxoSmithKline | 2024-09-30 |
| A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD) (NCT06551142) | GlaxoSmithKline | 2024-09-30 |
| A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease (NCT06613698) | GlaxoSmithKline | 2024-09-27 |
| Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus) (NCT06497504) | GlaxoSmithKline | 2024-09-17 |
| A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease (NCT06572384) | GlaxoSmithKline | 2024-09-11 |
| Safety, Tolerability and Blood Sampling of GSK3923868 Administered Via Dry Powder Inhaler to Healthy Participants of Chinese, Japanese and European Ancestry (NCT06577597) | GlaxoSmithKline | 2024-09-02 |
| A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants (NCT06576271) | GlaxoSmithKline | 2024-09-02 |
| A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive (NCT06433921) | GlaxoSmithKline | 2024-08-14 |
| A Study on the Immune Response, Safety and the Occurrence of Respiratory Syncytial Virus (RSV)-Associated Respiratory Tract Illness After Administration of RSV OA Vaccine in Adults 60 Years and Older (NCT06551181) | GlaxoSmithKline | 2024-08-05 |
| An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study (NCT06534892) | GlaxoSmithKline | 2024-08-01 |
| Study of the Effect of HFA-152a and HFA-134a Propellants on Mucociliary Clearance in Healthy Participants (NCT06506266) | GlaxoSmithKline | 2024-07-29 |
| Depemokimab Asthma Imaging and Bronchoscopy Sub-Study (NCT06979323) | GlaxoSmithKline | 2024-07-19 |
| Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers (NCT06422767) | GlaxoSmithKline | 2024-07-18 |
| A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1) (NCT06431594) | GlaxoSmithKline | 2024-07-02 |
| Retrospective Analysis of Systemic Glucocorticoid Mediated Long-term Effects, Patient Pathways and Economic Burden Across Multiple Indications (NCT06488703) | GlaxoSmithKline | 2024-07-01 |
| A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC) (NCT06472076) | GlaxoSmithKline | 2024-06-10 |
| A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) (NCT06411249) | GlaxoSmithKline | 2024-06-06 |
| Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis. (NCT06447506) | GlaxoSmithKline | 2024-06-05 |
| A Study to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152A (Test) or HFA-134A (Reference) in Healthy Participants Aged 18 to 55 Inclusive (NCT06433908) | GlaxoSmithKline | 2024-06-04 |
| A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Autoimmune Disease (NCT06413511) | GlaxoSmithKline | 2024-06-03 |
| A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma (NCT06261957) | GlaxoSmithKline | 2024-05-31 |
| A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults (NCT06431607) | GlaxoSmithKline | 2024-05-23 |
| A Study of Dostarlimab in Combination With Carboplatin-paclitaxel in Japanese Participants With Primary Advanced or Recurrent Endometrial Cancer (NCT06317311) | GlaxoSmithKline | 2024-05-07 |
| A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above (NCT06374394) | GlaxoSmithKline | 2024-04-29 |
| A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults (NCT06382311) | GlaxoSmithKline | 2024-04-18 |
| Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma (NCT06372496) | GlaxoSmithKline | 2024-04-16 |
| A Study to Investigate the Pharmacokinetics of a Combined Oral Contraceptive When Given Alone and in Combination With GSK3036656 in Female Participants of Non-childbearing Potential Aged 18 to 65 Years of Age (NCT06354257) | GlaxoSmithKline | 2024-04-05 |
| A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF) (NCT06317285) | GlaxoSmithKline | 2024-04-04 |
| A Study on the Immune Response and Safety of Inactivated Poliovirus Vaccine (IPV) When Co-administered With Human Rotavirus (HRV) Porcine Circovirus (PCV)-Free Vaccine in Healthy Chinese Infants (NCT06331156) | GlaxoSmithKline | 2024-03-22 |
| A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma (NCT06256588) | GlaxoSmithKline | 2024-03-21 |
| Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH (NCT06104319) | GlaxoSmithKline | 2024-01-22 |
| A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants (NCT06213506) | GlaxoSmithKline | 2024-01-15 |
| A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy Participants (NCT06188507) | GlaxoSmithKline | 2024-01-12 |
| A Study to Assess the Safety and Immune Response of Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) in Participants Aged 65 Years and Older in India (NCT05648357) | GlaxoSmithKline | 2023-12-14 |
| A Study to Investigate the Safety of GSK4024484 in Healthy Adult Participants (NCT06171113) | GlaxoSmithKline | 2023-12-11 |
| A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease (NCT06154837) | GlaxoSmithKline | 2023-11-27 |
| A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis (NCT05999799) | GlaxoSmithKline | 2023-11-16 |
| A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202 (NCT06062420) | GlaxoSmithKline | 2023-11-14 |
| A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age (NCT06113198) | GlaxoSmithKline | 2023-11-10 |
| A First Time in Human Study to Evaluate the Safety and Tolerability of GSK4381406 in Healthy Participants (NCT05999708) | GlaxoSmithKline | 2023-10-31 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Anticancer Activity of GSK4524101 Alone or With Niraparib in Participants With Solid Tumors (NCT06077877) | GlaxoSmithKline | 2023-10-24 |
| Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease (NCT06079190) | GlaxoSmithKline | 2023-10-20 |
| A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS (NCT05340257) | GlaxoSmithKline | 2023-10-14 |
| A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Prefilled Syringe Fitted With a Safety Syringe Device in Healthy Adult Participants (NCT06058390) | GlaxoSmithKline | 2023-10-04 |
| Concentration-QT Study of Paroxetine in Healthy Adults (NCT06065735) | GlaxoSmithKline | 2023-10-02 |
| A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain (NCT05838755) | GlaxoSmithKline | 2023-09-20 |
| A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease (NCT05878717) | GlaxoSmithKline | 2023-09-13 |
| A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain (NCT05838742) | GlaxoSmithKline | 2023-09-13 |
| Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P) (NCT05682326) | GlaxoSmithKline | 2023-09-06 |
| Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix Porcine Circovirus (PCV)-Free Liquid Compared to Rotarix Liquid Given in 2-doses in Healthy Chinese Infants Starting at Age 6-16 Weeks (NCT06025695) | GlaxoSmithKline | 2023-09-01 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 Years (NCT05660265) | GlaxoSmithKline | 2023-08-26 |
| Bioequivalence Study Between Two Albendazole 400 mg Tablets in Healthy Adult Participants Under Fed Conditions (NCT06201559) | GlaxoSmithKline | 2023-08-21 |
| A Study on the Reactogenicity, Safety and Immune Response of a Targeted Immunotherapy Against HSV in Healthy Japanese Participants Aged 18-40 Years (NCT05989672) | GlaxoSmithKline | 2023-08-08 |
| A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults (NCT05972993) | GlaxoSmithKline | 2023-08-07 |
| Safety and Immunogenicity of Different Formulations of Monovalent Influenza A/Astrakhan/3212/2020 Like (H5N8) Virus Vaccine With AS03 Adjuvant System in Medically Stable Adults (NCT05975840) | GlaxoSmithKline | 2023-08-03 |
| A Study on the Safety and Immune Response of Investigational COVID-19 mRNA Vaccines in Healthy Adults (NCT05960097) | GlaxoSmithKline | 2023-08-01 |
| A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults (NCT05966090) | GlaxoSmithKline | 2023-07-28 |
| A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above (NCT05921903) | GlaxoSmithKline | 2023-07-28 |
| A Study of Belimumab in Chinese Pediatric Participants With Systemic Lupus Erythematosus (NCT05917288) | GlaxoSmithKline | 2023-07-07 |
| A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments (NCT05714839) | GlaxoSmithKline | 2023-06-14 |
| Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults (NCT05879107) | GlaxoSmithKline | 2023-05-26 |
| A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (NCT05823974) | GlaxoSmithKline | 2023-04-27 |
| A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma (NCT05757102) | GlaxoSmithKline | 2023-04-25 |
| Drug Interaction Assessment of GSK3882347 in Healthy Participants Aged 18 to 65 Years (NCT05760261) | GlaxoSmithKline | 2023-04-11 |
| Green (Sustainable) VENTOLIN - Pharmacokinetics (PK) Study in Healthy Participants (NCT05791565) | GlaxoSmithKline | 2023-04-03 |
| A Study of Dostarlimab in Untreated dMMR/MSI-H Locally Advanced Rectal Cancer (NCT05723562) | GlaxoSmithKline | 2023-04-03 |
| A Study in Healthy Japanese Participants to Evaluate the Safety and Pharmacokinetics of Otilimab (NCT05304130) | GlaxoSmithKline | 2023-02-08 |
| A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control (NCT05705440) | GlaxoSmithKline | 2023-02-07 |
| Phase 1, Single and Repeat Dose Study to Assess Safety, Tolerability, and Pharmacokinetics (PK) of GSK3923868 in Participants With Chronic Obstructive Pulmonary Disease (COPD) (NCT05677347) | GlaxoSmithKline | 2023-01-23 |
| A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis) (NCT05630833) | GlaxoSmithKline | 2023-01-11 |
| Phase 2b Study of GSK4532990 in Adults With NASH (NCT05583344) | GlaxoSmithKline | 2023-01-02 |
| A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age (NCT05630846) | GlaxoSmithKline | 2022-12-14 |
| A Study to Compare the Pharmacokinetics (PK) of Depemokimab When Delivered With a Safety Syringe Device (SSD) or an Autoinjector in Healthy Adult Participants (NCT05602025) | GlaxoSmithKline | 2022-12-13 |
| Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1) (NCT05630807) | GlaxoSmithKline | 2022-12-07 |
| Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2) (NCT05630820) | GlaxoSmithKline | 2022-12-06 |
| Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults (NCT05613205) | GlaxoSmithKline | 2022-11-28 |
| Safety and Efficacy of GSK Neisseria Gonorrhoeae GMMA (NgG) Investigational Vaccine When Administered to Healthy Adults 18 to 50 Years of Age (NCT05630859) | GlaxoSmithKline | 2022-11-28 |
| An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection (NCT04494412) | GlaxoSmithKline | 2022-11-21 |
| Safety, Immunogenicity and Efficacy of GSK S. Aureus Candidate Vaccine (GSK3878858A) When Administered to Healthy Adults (Dose-escalation) and to Adults 18 to 64 Years of Age With a Recent S. Aureus Skin and Soft Tissue Infection (SSTI) (NCT04420221) | GlaxoSmithKline | 2022-11-16 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age Inclusive (NCT05590338) | GlaxoSmithKline | 2022-11-04 |
| A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adults 60 Years of Age and Above (NCT05590403) | GlaxoSmithKline | 2022-10-28 |
| A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above (NCT05559476) | GlaxoSmithKline | 2022-10-20 |
| A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and Above (NCT05568797) | GlaxoSmithKline | 2022-10-14 |
| To Evaluate Real-World Effectiveness of Fluticasone Furoate/Umeclidinium Bromide/Vilanterol (FF/UMEC/VI) in a Single Inhaler (Trelegy Ellipta) in Participants With Symptomatic COPD (NCT05535972) | GlaxoSmithKline | 2022-10-14 |
| A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer (NCT05565378) | GlaxoSmithKline | 2022-10-14 |
| A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years (NCT05561673) | GlaxoSmithKline | 2022-10-04 |
| A Phase 1, Open Label Study of Intravenous GSK3745417 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Determine RP2D & Schedule in Participants With Relapsed or Refractory Myeloid Malignancies Including AML and HR MDS (NCT05424380) | GlaxoSmithKline | 2022-09-20 |
| A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella and Typhoid Fever (NCT05480800) | GlaxoSmithKline | 2022-09-13 |
| Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial (NCT05334368) | GlaxoSmithKline | 2022-09-06 |
| Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM (NCT07150104) | GlaxoSmithKline | 2022-08-31 |
| A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age (NCT05496231) | GlaxoSmithKline | 2022-08-22 |
| Safety and Immunogenicity Study of a Booster Dose of the Investigational CV0501 mRNA COVID-19 Vaccine in Adults at Least 18 Years Old (NCT05477186) | GlaxoSmithKline | 2022-08-12 |
| Food Effect Study of Linerixibat Tablets in Healthy Adult Participants (NCT05435170) | GlaxoSmithKline | 2022-08-11 |
| A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults (NCT05371080) | GlaxoSmithKline | 2022-08-10 |
| A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (NCT05446740) | GlaxoSmithKline | 2022-08-09 |
| Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis (NCT05382312) | GlaxoSmithKline | 2022-07-26 |
| Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM (NCT07150091) | GlaxoSmithKline | 2022-07-19 |